I am a medical doctor and currently working towards obtaining a PhD in the department of Public Health and Primary Care. My current research focuses on the evaluation of DNA methylation markers of human genes and the Human Papillomavirus gene in cervical cancer pathogenesis and how these can be used to improve current diagnostic tools and screening protocols. I completed my Master’s degree in Public Health at the Johns Hopkins Bloomberg School of Public Health, United States of America, where my concentration was in Epidemiology and Biostatistical Methods in Public Health, in 2010. I am currently affiliated with the Institute of Human Virology, Nigeria where I coordinate a large multi-center prospective study of 10 000 women in a study focused on the associations between high risk HPV infection, the vaginal microenvironment, HPV genomics, germline and somatic mutations in the aetiology of cervical cancer. I am also involved in HIV program implementation and I manage a large patient level database of over 180 000 persons living with HIV in Nigeria.
My current research lies in the identification of novel biomarkers in cervical cancer prevention using modern molecular techniques in epigenetics research and evaluating the interactions between the human host and the vaginal micro-environment in cervical cancer pathogenesis.
Odutola MK*, Jedy-Agba E*, Dareng E*, et. al. Burden of cancers attributable to infectious agents in Nigeria: 2012-2014. Front. Oncol. 6:216. doi: 10.3389/fonc.2016.00216
Oga EA, Brown JP, Brown C, Dareng E, et al. Recurrence of cervical intraepithelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women. BMC women’s health. 2016;16:25.
Isa Modibbo F, Bamisaye P, Dareng E*et al. Qualitative study of barriers to cervical cancer screening among Nigerian women. BMJ open. 2016;6(1):e008533.
Dareng EO, Jedy-Agba E, Bamisaye P, et al. Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening. PloS one. 2015;10(11):e0141679.
Akarolo-Anthony SN, Famooto AO, Dareng EO, et al. Age-specific prevalence of human papilloma virus infection among Nigerian women. BMC public health. 2014;14:656.
Dareng EO, Ma B, Famooto AO, et al. Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women. Epidemiol Infect. 2015:1-15.
Research capacity. Enabling the genomic revolution in Africa. Science. 2014;344:1346-1348.(Dareng E as part of the H3Africa Consortium)
Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, Dareng EO, et al. HIV associated high-risk HPV infection among Nigerian women. BMC Infectious Diseases. 2013;13:521.
Famooto A, Almujtaba M, Dareng E, et al. RPS19 and TYMS SNPs and prevalent high risk Human Papilloma Virus infection in Nigerian women. PLoS One.2013;8(11):e66930.